Depakine: Sanofi condemned for lack of information on the leaflet
The court considered that the risk of autistic disorders in connection with Depakine were known to ...
Read moreThe court considered that the risk of autistic disorders in connection with Depakine were known to ...
Read moreDid you miss the news this early morning? We've put together a recap to help you ...
Read moreSanofi makes its mea culpa. The French pharmaceutical giant admitted Tuesday, during its general meeting, to ...
Read moreThe Sanofi group will invest 1.5 billion euros to develop mRNA technology in these research centers. ...
Read moreSanofi and GSK, which co-developed this vaccine, will seek regulatory approval for their product in the ...
Read moreAfter a year of delay and multiple postponements, Sanofi's anti-covid vaccine could finally see the light ...
Read moreA decision that leaves the employees concerned bitter. The pharmaceutical group Sanofi has found a buyer ...
Read moreThe Paris court ruled that Sanofi had "committed a fault by failing to comply with its ...
Read moreThe Sanofi laboratory pinned down. The pharmaceutical giant was held responsible, Wednesday, January 5, by the ...
Read moreNew twist in the Dépakine file. The Paris court ruled on Wednesday that Sanofi had "committed ...
Read more© Paudal 2021. All Rights Reserved.